Importance Pulmonary arterial hypertension (PAH) is a subtype of pulmonary hypertension
(PH), characterized by pulmonary arterial remodeling. The prevalence of PAH is …

Obesity is a prevalent global public health issue characterized by excess body fat. Adipose
tissue is now recognized as an important endocrine organ releasing an abundance of …

The identification of systemic inflammation (SI) as a central player in the orchestration of
acute‐on‐chronic liver failure (ACLF) has opened new avenues for the understanding of the …

Portopulmonary hypertension (PoPH) is defined as pulmonary arterial hypertension (PAH)
associated with portal hypertension and is a subset of Group 1 pulmonary hypertension …

Pulmonary arterial hypertension (PAH) is a complex disease of multifactorial origin. While
registries have demonstrated that women are more susceptible to the disease, females with …

Portopulmonary hypertension (PoPH) is a type of pulmonary vascular disease due to portal
hypertension that exhibits high morbidity and mortality. The mechanisms driving disease are …

Pulmonary arterial hypertension (PAH) is a rare disease characterised by pulmonary
vascular remodelling and elevated pulmonary pressure, which eventually leads to right …

Portal hypertension from chronic liver disease leads to the formation of collateral blood
vessels called spontaneous portosystemic shunts (SPSS). These shunts may form from …

Portopulmonary hypertension (POPH) affects 5% to 6% of patients with advanced liver
disease and accounts for 5% to 15% of pulmonary arterial hypertension (PAH) cases …

Background and Aims. There are few studies on the prevalence and clinical characteristics
of portopulmonary hypertension (POPH) in patients with portal hypertension. In addition …